Related Experiment Videos
[The bronchodilating effect of pirenzepine]
T Shioya1, M Kagaya, A Onodera
1Second Department of Internal Medicine, Akita University School of Medicine.
Arerugi = [Allergy]
|October 1, 1991
Summary
Pirenzepine (PZ) significantly improved lung function in asthma patients by dilating airways. This bronchodilating effect is linked to PZ
Area of Science:
- Pharmacology
- Respiratory Medicine
- Physiology
Context:
- Asthma is a chronic respiratory disease characterized by airway inflammation and hyperresponsiveness.
- Bronchodilators are essential for managing asthma symptoms.
- Pirenzepine (PZ), a muscarinic antagonist, has been investigated for its potential therapeutic effects.
Purpose:
- To investigate the bronchodilating effects of pirenzepine (PZ) in asthmatic patients.
- To elucidate the mechanism underlying PZ's effect on airway smooth muscle.
- To assess PZ's impact on respiratory parameters like FVC, FEV1.0, and PEFR.
Summary:
- Intravenous administration of 20 mg PZ significantly increased FVC (15%), FEV1.0 (29%), and PEFR (37%) in asthmatic patients.
- In canine models, PZ inhibited acetylcholine-induced and vagal nerve stimulation-induced tracheal smooth muscle contractions.
- These findings suggest PZ's bronchodilating action is mediated by M1 and M3 muscarinic receptor inhibition.
Impact:
- Pirenzepine demonstrates potential as a bronchodilator for asthma management.
- Understanding PZ's mechanism provides insights into muscarinic receptor roles in airway function.
- This research contributes to the development of novel therapeutic strategies for respiratory diseases.